The trademark application BONAPH1DE was filed by Alnylam Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 13, 2021, and it was registered by office on September 20, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and address of the trademark registration was recorded on December 1, 2022. Appointment and Replacement of representative of the trademark registration was recorded on June 19, 2023.